On Oct. 12, a Las Vegas jury was excused after a confidential resolution was reached in a civil trial regarding Actos, a diabetes drug. The medication is used in conjunction with diet and exercise to improve control of blood sugar in adults with type 2 diabetes mellitus. “We use the... Read more »

According to a recent announcement by Actos manufacturer Takeda Pharmaceuticals, over 96 percent of the eligible claimants have agreed to take part in the Actos product liability resolution program. Through the program, over 9,000 plaintiffs may receive compensation for their injuries without the uncertainty that exists in continued litigation. With over... Read more »

The latest Actos trial to begin in U.S. courts started on Thursday, August 27 in Las Vegas, under the direction of Judge Jerry Wiese II. Attorneys working for two southern Nevada claimants argue that their clients suffered severe side effects from the diabetes drug, including death. The trial is expected to... Read more »

Actos, a type 2 diabetes medication that has been linked in some studies to an increased risk of bladder cancer, is now suspected of raising the risk of other types of cancer as well. In addition to the much publicized Actos side effects to date, emerging research has determined that the... Read more »

On July 15, 2015, an Ohio resident and his wife filed an Actos bladder cancer lawsuit against both Takeda Pharmaceuticals and Eli Lilly, Inc. alleging severely inadequate warnings as to the increased risks associated with the Type II diabetes drug. The lawsuit, which was filed in United States District Court... Read more »

A number of plaintiffs from Tucson, AZ have filed an Actos lawsuit against Takeda Pharmaceuticals citing personal injury, wrongful death and/or loss of consortium. They claim that use of the drug caused them to develop bladder cancer. Their lawsuits will be added to the ongoing multidistrict litigation in Louisiana. Actos,... Read more »

Last week, Takeda Pharmaceuticals agreed to a $2.4 billion Actos settlement – one of the pharmaceutical industry’s largest settlements. The announcement was welcome news for the thousands of individuals who filed Actos lawsuits in state and federal courts. “After years of hard-fought and contentious litigation, the defendants have finally stepped... Read more »

When is paying $2.2 billion ever a bargain? According to University of Michigan professor and class action settlement expert Eric Gordon, Japanese drug giant Takeda’s decision to offer one of the largest drug settlements in US history to settle 8,ooo pending lawsuits against it may be just that. Actos users... Read more »

The diabetes drug Actos has been named in several thousand product liability lawsuits across the United States. Accordingly, the cases have been consolidated pursuant to the rules of multidistrict litigation (MDL) – a process which funnels near-identical civil lawsuits into a single litigation tract for purposes of eliminating duplicative routine... Read more »

Twelve plaintiffs have filed lawsuits against Takeda Pharmaceuticals, claiming the drug caused their spouse or themselves to develop bladder cancer. Each Actos lawsuit will be added to the ongoing multidistrict litigation in the Western District of Louisiana. Actos is an oral diabetes medication used to control blood sugar levels in... Read more »